셀트리온제약: directors' dealings · South Korea · DART (FSS) DART:company-33c63d KR KR · DART (FSS) Mcap 2569.1Bn€
Explore the full management transaction log of 셀트리온제약, a listed equity based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Market capitalisation: €2,569.1bn. The latest transaction was disclosed on 10 April 2026 — Purchase. Among the most active insiders: 셀트리온. The full history is accessible without an account.
Financial data FY ended December 2025 · cache
Income statement
Revenue 536.40 Bn€
Gross profit 163.78 Bn€ 31% margin
Net income 38.75 Bn€ 7.2% margin
Balance sheet & cash
Market cap 2569.09 Bn€
Total debt 161.31 Bn€
Free Cash Flow 68.51 Bn€
Last declaration on 10 April 2026
Declarations 7 total
Executives ● Purchase2 DART
€16m 483,572 shares
DART:20260410003225 · 10 Apr 2026
Ideal exit: 5 Jan 2027 (T+270) Executives ● Purchase2 DART
DART:20260410003220 · 10 Apr 2026
Ideal exit: 5 Jan 2027 (T+270) Executives ● Purchase15 DART
€2 8 shares @ €0.289 0.0000% mcap 100.0% of flow
DART:20260403003148 · 24 Mar 2026
Ideal exit: 19 Dec 2026 (T+270) Executives ● Purchase19 DART
€33 114 shares @ €0.289 0.0000% mcap 100.0% of flow
DART:20260403003066 · 24 Mar 2026
Ideal exit: 19 Dec 2026 (T+270) Executives ● Purchase30 DART
€30 105 shares @ €0.289 0.0000% mcap 100.0% of flow
DART:20260403003030 · 24 Mar 2026
Ideal exit: 19 Dec 2026 (T+270) Executives ● Purchase15 DART
€55 191 shares @ €0.289 0.0000% mcap 100.0% of flow
DART:20260403003049 · 24 Mar 2026
Ideal exit: 19 Dec 2026 (T+270) Executives ● Purchase19 DART
€48 165 shares @ €0.289 0.0000% mcap 100.0% of flow
DART:20260403003087 · 24 Mar 2026
Ideal exit: 19 Dec 2026 (T+270)